BR112015019097A2 - carboditioato e o processo de preparação do mesmo - Google Patents

carboditioato e o processo de preparação do mesmo

Info

Publication number
BR112015019097A2
BR112015019097A2 BR112015019097A BR112015019097A BR112015019097A2 BR 112015019097 A2 BR112015019097 A2 BR 112015019097A2 BR 112015019097 A BR112015019097 A BR 112015019097A BR 112015019097 A BR112015019097 A BR 112015019097A BR 112015019097 A2 BR112015019097 A2 BR 112015019097A2
Authority
BR
Brazil
Prior art keywords
carbodithioate
compounds
formula
preparation process
substituted
Prior art date
Application number
BR112015019097A
Other languages
English (en)
Inventor
Sarswat Amit
Jain Ashish
Gupta Gopal
Prasad MAIKHURI Jagdamba
Kumar Lalit
Kumar Lokesh
Lal Nand
Jangir Santosh
Rawat Tara
Bala Veenu
Lal Sharma Vishanu
Original Assignee
Council Scient Ind Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council Scient Ind Res filed Critical Council Scient Ind Res
Publication of BR112015019097A2 publication Critical patent/BR112015019097A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/21—Radicals derived from sulfur analogues of carbonic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

resumo carboditioato e o processo de preparação do mesmo a presente invenção refere-se à síntese e avaliação biológica de compostos de fórmula i como agentes espermicidas, e o seu sal de ácido farmaceuticamente aceitável. a invenção proporciona bis (4- substituído-1-piperazinilthiocarbonil) dissulfureto (quando n = 0) e alcano-1, n-di-ilbis (4-substituído piperazina-1-carboditioato) (quando n = 0, 1, 2 ou 3) como mostrado na figura 1 do desenho anexo. estes compostos são considerados úteis para a actividade espermicida. fórmula i
BR112015019097A 2013-02-08 2014-01-10 carboditioato e o processo de preparação do mesmo BR112015019097A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN373DE2013 2013-02-08
PCT/IN2014/000023 WO2014122670A1 (en) 2013-02-08 2014-01-10 Carbodithioates with spermicidal activity and process for preparation thereof

Publications (1)

Publication Number Publication Date
BR112015019097A2 true BR112015019097A2 (pt) 2017-07-18

Family

ID=50137969

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015019097A BR112015019097A2 (pt) 2013-02-08 2014-01-10 carboditioato e o processo de preparação do mesmo

Country Status (5)

Country Link
CN (1) CN105143202B (pt)
AP (1) AP2015008642A0 (pt)
BR (1) BR112015019097A2 (pt)
WO (1) WO2014122670A1 (pt)
ZA (1) ZA201505621B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7206710B2 (ja) * 2018-09-04 2023-01-18 東ソー株式会社 ジチオカルバミン酸化合物、有機モリブデン錯体、及び潤滑油組成物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE345271B (pt) * 1967-12-14 1972-05-23 Astra Ab
JPH03148269A (ja) * 1989-11-01 1991-06-25 Nippon Chemiphar Co Ltd ピペラジン誘導体及びこれを含有する肝疾患治療剤
US6569375B1 (en) 2000-04-11 2003-05-27 Apex Medical Technologies, Inc. Vulcanization of dip-molded rubber articles with molten media baths
US20030161975A1 (en) 2002-02-27 2003-08-28 Lucas David M. Polyisoprene condom
US20040157837A1 (en) 2002-11-07 2004-08-12 Serbedzija George N. Combinations for the treatment of fungal infections
US20090054595A1 (en) 2007-08-21 2009-02-26 Yulex Corporation Compounding Formulations for Producing Articles from Guayule Natural Rubber
US8087412B2 (en) 2008-05-01 2012-01-03 Ansell Healthcare Products Llc Dip-formed synthetic polyisoprene latex articles with improved intraparticle and interparticle crosslinks
KR20170029019A (ko) 2008-07-18 2017-03-14 바이오모드 컨셉츠 인코포레이티드 활성 성분을 방출하는 제품
CN102417501A (zh) * 2011-09-02 2012-04-18 卞劲松 S-丹参素化合物、合成方法及用途

Also Published As

Publication number Publication date
AP2015008642A0 (en) 2015-08-31
ZA201505621B (en) 2016-07-27
CN105143202A (zh) 2015-12-09
CN105143202B (zh) 2018-08-14
WO2014122670A1 (en) 2014-08-14

Similar Documents

Publication Publication Date Title
CY1121549T1 (el) Ενωσεις 1-αρυλκαρβονυλ-4-oξυ-πιπεριδινης χρησιμες για την αγωγη νευροεκφυλιστικων παθησεων
ECSP16090152A (es) Compuesto heterocíclico que contiene nitrógeno
ECSP12011622A (es) Derivados de oxazina y su uso como inhibidores de bace para el tratamiento de trastornos neurológicos
BR112015032921A8 (pt) compostos de benzofuranila e benzoxazolila substituídos e utilizações dos mesmos
CL2017000469A1 (es) Derivados de tetrahidronaftaleno que inhiben la proteina mcl-1
UY35377A (es) Compuestos de 1,3-oxazin-2-amina fusionados con ciclopropilo perfluorado como inhibidores de beta-secretasa y métodos de uso
BR112015020787A2 (pt) inibidores quinazolínicos de formas mutantes ativantes do receptor do fator de crescimento epidérmico
BR112015028501A2 (pt) derivados de bipirazol como inibidores de jak
BR112012015916A2 (pt) derivados de pirazina e seu uso no tratamento de distúrbios neurológicos
BR112014010576A2 (pt) inibidores de neprilisina
DOP2015000245A (es) Derivados de 3-acetilamino-1 (fenil-heteroaril-aminocarbonil o fenil-heteroaril-carbonilamino) benceno para el tratamiento de desordenes hiperproliferativos
BR112015027055A8 (pt) bi-heteroarilas, usos das mesmas, e composição farmacêutica
BR112014018702A8 (pt) Composto, cristal, inibidor, medicamento, composição farmacêutica, e, uso de um composto ou sal
BR112013020270A2 (pt) derivados de pirazol microbicidas
BR112015020772A2 (pt) compostos de pirimidina e piridina e seu uso
BR112014005468A2 (pt) derivados de aminopiridina para uso como moduladores de atividade quinase
BR112014022214A2 (pt) fenólicos antibacterianos
BR112015018491A2 (pt) triterpenoides c-19-modificados com atividade inibidora de maturação de hiv
BR112015004029A2 (pt) Processo para preparação de teneligliptina, de um composto ou de sal ou hidrato do mesmo
BR112014024479A8 (pt) Formulações farmacêuticas compreendendo antagonistas de c-cr3
BR112014018341A8 (pt) Compostos aza-heterocíclicos
NI201500050A (es) Benzamidas
DOP2016000276A (es) 2-AMINO-6-METIL-4,4a,5,6-TETRAHIDROPIRANO[3,4-d][1,3]TIAZIN-8a(8H)-IL-1,3-TIAZOL-4-ILAMIDAS
BR112013020419A2 (pt) microbicidas derivados de pirazol
BR112018001035A2 (pt) compostos de fenoxiacetamidas aneladas, sal farmaceuticamente aceitável, seu método de síntese, combinação de medicamento e uso dos mesmos

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]